N- and P/Q-type Ca2+ channels mediate transmitter release with a similar cooperativity at rat hippocampal autapses

J Neurosci. 1998 Apr 15;18(8):2849-55. doi: 10.1523/JNEUROSCI.18-08-02849.1998.

Abstract

The relationship between extracellular Ca2+ concentration and EPSC amplitude was investigated at excitatory autapses on cultured hippocampal neurons. This relationship was steeply nonlinear, implicating the cooperative involvement of several Ca2+ ions in the release of each vesicle of transmitter. The cooperativity was estimated to be 3.1 using a power function fit and 3.3 using a Hill equation fit. However, simulations suggest that these values underestimate the true cooperativity. The role of different Ca2+ channel subtypes in shaping the Ca2+ dose-response relationship was studied using the selective Ca2+ channel blockers omega-agatoxin GIVA (omega-Aga), which blocks P/Q-type channels, and omega-conotoxin GVIA (omega-CTx), which blocks N-type channels. Both blockers broadened the dose-response relationship, and the Hill coefficient was reduced to 2.5 by omega-Aga and to 2.6 by omega-CTx. This broadening is consistent with a nonuniform distribution of Ca2+ channel subtypes across presynaptic terminals. The similar Hill coefficients in omega-Aga or omega-CTx suggest that there was no difference in the degree of cooperativity for transmitter release mediated via N- or P/Q-type Ca2+ channels. A model of the role of calcium in transmitter release is developed. It is based on a modified Dodge-Rahamimoff equation that includes a nonlinear relationship between extracellular and intracellular Ca2+ concentration, has a cooperativity of 4, and incorporates a nonuniform distribution of Ca2+ channel subtypes across presynaptic terminals. The model predictions are consistent with all of the results reported in this study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Animals
  • Cadmium / pharmacology
  • Calcium / pharmacokinetics
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / metabolism*
  • Calcium Channels, N-Type*
  • Dose-Response Relationship, Drug
  • Excitatory Amino Acid Agonists / pharmacology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / physiology
  • Extracellular Space / metabolism
  • Hippocampus / chemistry
  • Hippocampus / physiology*
  • Mathematics
  • Neurotransmitter Agents / metabolism*
  • Peptides / pharmacology
  • Presynaptic Terminals / chemistry
  • Presynaptic Terminals / drug effects
  • Presynaptic Terminals / physiology
  • Rats
  • Spider Venoms / pharmacology
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • Synaptic Vesicles / chemistry
  • Synaptic Vesicles / drug effects
  • Synaptic Vesicles / physiology
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / pharmacology
  • omega-Agatoxin IVA
  • omega-Conotoxin GVIA

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Calcium Channels, N-Type
  • Excitatory Amino Acid Agonists
  • Excitatory Amino Acid Antagonists
  • Neurotransmitter Agents
  • Peptides
  • Spider Venoms
  • omega-Agatoxin IVA
  • voltage-dependent calcium channel (P-Q type)
  • Cadmium
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
  • omega-Conotoxin GVIA
  • Calcium